Y-Intercept (HK)’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,671
Closed -$293K 1457
2022
Q3
$293K Buy
+5,671
New +$234K 0.03% 709

Other funds holding CCXI

Y-Intercept (HK)'s CCXI Position: Q4 2022 in Review

Y-Intercept (HK) sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 5,671 shares — an estimated $293K sold.

Y-Intercept (HK) first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $293K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Y-Intercept (HK) reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 5,671 ChemoCentryx, Inc. shares in Q4 2022, an estimated $293K.
  • Y-Intercept (HK) first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s ChemoCentryx, Inc. position peaked at $293K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Y-Intercept (HK)'s 13F filing for Q4 2022, filed 14 Feb 2023.